Australian Society of Cytology - Pursuit of Excellence
Australian Society of Cytology

Case of the Month

June 2002 - Answer and Discussion

Cryptococcus neoformans var. gattii



The bronchial brushings and washings show encapsulated organisms consistent with cryptococcus.

A bronchial biopsy, taken at the same time, shows cryptococcus in fragments of blood and fibrin.

bronchial biopsy H&E 60x bronchial biopsy PASD 60x
Bronchial biopsy
H&E stain 60x
Bronchial biopsy
PASD stain 60x

Microbiology were able to culture and identify Cryptococcus neoformans var. gattii from the bronchial washings.

indian ink preparation indian ink preparation
Indian ink preparation Indian ink preparation



Cryptococcus neoformans is a yeast with blastospores generally spherical 5 - 30 um in diameter, with a thick mucopolysaccharide capsule. The capsule stains with mucin stains such as PASD. They can be identified in wet preparations by negative staining with India ink. Cryptococcus neoformans lives naturally in soil contaminated with bird droppings, especially from pigeons and other seed-eating birds (Cryptococcus neoformans var. neoformans), or eucalyptus trees and decaying wood forming hollows in living trees(Cryptococcus neformans var. gattii).

The respiratory tract is thought to be the portal of entry for most infections. The most common infection identified is meningoencephalitis, followed by localised abscesses or granulomas in the lungs, brain, lymph nodes, skin or bones. Diffuse pulmonary infection is probably the most common type of infection but it is often asymptomatic and not detected. Cryptococcus has a low level of pathogenicity for normal adults. Unlike var. neoformans, which is mostly seen in immunocompromised patients, var. gattii infects immunocompetent hosts. Large mass lesions (cryptococcomas) in the lung and/or brain are the most common clinical presentation of var. gattii. The usual treatment is combination therapy with amphotericin B and 5-fluorocytosine or ketoconazole.


Copyright © All rights reserved. No part of this publication may be reproduced in any form or by any means without the permission of the author or Medvet Science Pty Ltd, the commercial agent for the Institute of Medical and Veterinary Science providing advice regarding protection of intellectual property
(e-mail address: Email Link intprop@medvet.com.au).


 

Return to top of page

Email MavilPro